Figure 1
From: Formulation and evaluation of chitosan solid lipid nanoparticles of carbamazepine

FTIR spectra CBZ (A), Chitosan (B) Tristearin (C), Physical mixture of CBZ and Tristearin (D) and CBZ SLN (E).
From: Formulation and evaluation of chitosan solid lipid nanoparticles of carbamazepine
FTIR spectra CBZ (A), Chitosan (B) Tristearin (C), Physical mixture of CBZ and Tristearin (D) and CBZ SLN (E).